Answer
Yes. Report new or worsening numbness, tingling, altered sensation or weakness promptly.
Sources for this answer
- Eribulin Baxter 0.44 mg/mL solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.